Insider Transactions Reported by 13 Insiders of Paratek Pharmaceuticals, Inc.

Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 09 Jan 2025

Paratek Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JAMES DONDERO 10%+ Owner $4,743,200 17 Mar 2023
MICHAEL BIGHAM Exec. Chairman of the Board, Director 08 Aug 2023
Evan Loh CEO, Director 21 Sep 2023
William M. Haskel CLO, General Counsel & Sec. 21 Sep 2023
Timothy R. Franson Director 21 Sep 2023
Jeffrey Stein Director 21 Sep 2023
Robert S. Radie Director 21 Sep 2023
Kristine Peterson Director 21 Sep 2023
Adam Woodrow President & Chief Commercial 21 Sep 2023
Minnie Baylor-Henry Director 21 Sep 2023
Thomas John Dietz Director 21 Sep 2023
Randall B. Brenner Chief Development & Regulatory 21 Sep 2023
Rolf K. Hoffmann Director 21 Sep 2023

Recent Insider Transactions by Companies or Individuals for Paratek Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.